Harbor Group’s Pfizer PFE Stock Holding History

Harbor Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,149	Closed	-$213K	–	66
2022 Q4	$213K	Buy	+4,149	New	+$199K	0.14%	50
2021 Q2	–	Sell	-5,898	Closed	-$228K	–	52
2021 Q1	$228K	Sell	5,898 -45	-0.8%	-$1.6K	0.16%	46
2020 Q4	$219K	Buy	+5,943	New	+$218K	0.16%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbor Group's PFE Position: Q1 2023 in Review

Harbor Group sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,149 shares — an estimated $213K sold.

Harbor Group first reported a position in PFE in Q4 2020 and held it in 3 quarters. The position peaked at $228K in Q1 2021. 3,105 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Harbor Group reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Harbor Group sold 4,149 Pfizer shares in Q1 2023, an estimated $213K.
Harbor Group first reported a position in Pfizer in Q4 2020 and held it in 3 quarters.
Harbor Group's Pfizer position peaked at $228K in Q1 2021.
3,105 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Harbor Group's 13F filing for Q1 2023, filed 11 Apr 2023.